DDDL reviewed literature and edited the manuscript
The Science Behind Glutathione and Hair Health Recent scientific studies have begun to uncover the mechanisms through which glutathione might support hair health
Clinical Evidence In a 2021 clinical trial (SURPASS-2), tirzepatide was found to have greater reductions in hemoglobin A1c (HbA1c) and body weight than semaglutide 1 mg in people with type 2 diabetes [6]
Discovery of JANUVIA TM (sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
Stress management becomes especially important during this phase, as the anxiety about hair loss can elevate cortisol and worsen the problem
To assess the association of semaglutide with incident CUD, the study population included 587,849 patients with T2D who had active medical encounters for T2D during 12/20175/2021, were for the first time prescribed semaglutide (Ozempic) or non-GLP1-1RA anti-diabetes medications (new-user design) during 12/20175/2021(index event), had no diagnosis of CUD on or before the index event and had a diagnosis of at least one of obesity-associated comorbidities (T2D, hypertension, hypercholesterolemia, hyperlipidemia, heart diseases, stroke) on or before the index event